The central pharmacy is the hospital's medication-manufacturing and distribution hub — part cleanroom factory, part secured warehouse, part clinical workspace. This article frames the program-level decisions that set everything downstream: the service model the pharmacy will run, the functional spaces that model requires, and how those spaces are sized and located within the building. It is the orienting decision-set that the rest of the pharmacy Part builds on; sister Articles then detail the distribution network, the cleanrooms, the building systems, and activation.
The central (or "main") inpatient pharmacy is the single licensed location from which the hospital's drug supply is procured, stored, compounded, packaged, and dispatched to patient-care areas. Unlike most clinical departments — which are essentially rooms for people and equipment — the pharmacy is simultaneously several different building types stacked into one suite:
Because each of these has its own code regime, the pharmacy carries more independent compliance gates than almost any other space in the hospital: FGI Guidelines for Design and Construction, ASHRAE 170 for ventilation, USP <797>/<800> for compounding, the state Board of Pharmacy licensing rules, DEA security regulations, NFPA 99 and NFPA 101 life safety, and the AHJ's adopted building and fire codes. The cleanroom-certification milestone late in construction is one of the genuinely hard gates in the entire project — a suite that fails air-classification or pressure-cascade testing cannot open, regardless of how complete the rest of the building is.
Before any room is sized, the owner and pharmacy leadership must commit to a service model: how the pharmacy will actually operate. This is a clinical-operations decision with very large facility consequences, and it must be locked early because it determines square footage, adjacencies, infrastructure, and automation. The major axes of the decision are:
Centralized vs. decentralized distribution. A centralized model keeps most compounding and dispensing in the main pharmacy and pushes doses out to the floors. A decentralized model relies heavily on automated dispensing cabinets (ADCs) and pharmacy satellites located in or near patient-care units, with pharmacists practicing on the units. Most modern U.S. hospitals run a hybrid: a strong central pharmacy for compounding and bulk distribution, a broad ADC network for routine and first-dose medications, and selective satellites for high-acuity areas (OR, ED, oncology, NICU). The central-pharmacy program described here assumes that hybrid baseline; the ADC and satellite network is detailed in the sibling distribution Article.
Insource vs. outsource sterile compounding. Compounded sterile preparations (CSPs) can be made in-house in a USP <797> suite, or purchased from a licensed outsourcing facility (a 503B registered with the FDA). Many systems outsource high-volume, ready-to-administer products to reduce in-house cleanroom load and risk, while retaining in-house capability for patient-specific, short-dated, and urgent preparations. The insource/outsource split directly sizes the cleanroom suite — a heavily outsourced operation may need a far smaller (or simpler) sterile suite, while a system standardizing on in-house batch compounding needs a larger, more redundant one.
Manual vs. automated. The degree of automation — carousels and inventory robots in storage, robotic IV compounding in the cleanroom, automated repackaging and unit-dose packaging, and the ADC network on the floors — is a capital and workflow decision that reshapes the floor plan, the power and data infrastructure, and the staffing model. Automation choices are detailed in the systems-and-automation Chapter; at the program level the key point is that automation must be decided early because robots and carousels carry structural, electrical, cooling, and ceiling-height requirements that cannot be retrofitted cheaply.
Service scope. Will this pharmacy support oncology/chemotherapy (driving USP <800> hazardous compounding)? Investigational drugs and research (driving a controlled, segregated investigational-drug area)? Nuclear medicine radiopharmaceuticals (a separate radiation-controlled space, often programmed independently)? Total parenteral nutrition (TPN) batch compounding? Pediatric/neonatal dosing? Each scope element adds dedicated space and infrastructure.
Hours and acuity. A 24/7 operation supporting a high-acuity, large-bed hospital has different staffing, security, and redundancy requirements than a small community hospital pharmacy. Bed count, case mix, surgical volume, and the presence of an ED, oncology, and ICU services all scale demand.
These choices should be captured in a written pharmacy operational plan / functional program that the design team treats as fixed input. Re-litigating the service model after schematic design is one of the most common and costly sources of pharmacy rework.
A complete central pharmacy program typically includes the following functional zones. Not every hospital needs all of them, and several can be combined in smaller facilities — but each represents a distinct set of requirements, and the program should explicitly include or consciously exclude each one.
| Functional zone | Purpose | Notable requirements |
|---|---|---|
| Receiving / loading | Intake of bulk drug shipments, cold-chain deliveries, returns | Secure, near a dock; tie to cold-chain and controlled-substance receipt |
| Bulk & active storage | Shelving, carousels, refrigerators/freezers for the working inventory | Temperature monitoring; high density; structural load if automated |
| Controlled-substance vault | DEA-compliant storage of Schedule II–V drugs | Substantial construction, alarmed, access-controlled, logged |
| Non-sterile compounding | Oral liquids, ointments, repackaging per USP <795> | Containment for any hazardous non-sterile work |
| Sterile compounding suite (USP <797>) | IV admixtures, CSPs in ISO-classified cleanrooms | Anteroom + buffer room, pressure cascade, HEPA, ISO Class 5 PECs |
| Hazardous-drug suite (USP <800>) | Chemo and other hazardous-drug compounding | Negative-pressure room, externally vented C-PEC, segregated storage |
| Repackaging / unit-dose / packaging | Bar-coded unit-dose packaging, automated packagers | Power, data, bench/equipment space; bar-code verification |
| Order entry / clinical workroom | Pharmacist verification, clinical pharmacy, EHR workstations | Quiet, well-lit, ergonomic; reliable IT and power |
| Investigational drug service | Segregated storage and handling of research drugs | Access control, separate inventory, often a small dedicated room |
| Refrigeration / cold storage | Pharmaceutical-grade refrigerators and freezers | Dedicated/emergency power, continuous monitoring and alarms |
| Administrative / office | Director, managers, residents, education, breakroom | Standard office program; staff support |
| Staff support | Gowning support, lockers, restrooms (outside classified zones) | Per FGI staff-support requirements |